| Literature DB >> 15781491 |
Masayuki Sakurai1, Takashi Ohtsuki, Kimitsuna Watanabe.
Abstract
The mitochondria of the nematode Ascaris suum have tRNAs with unusual secondary structures that lack either the T-arm or D-arm found in most other organisms. Of the twenty-two tRNA species present in the mitochondria of A.suum, twenty lack the entire T-arm and two serine tRNAs lack the D-arm. To understand how such unusual tRNAs work in the nematode mitochondrial translation system, we analyzed post-transcriptional modifications of 11 mitochondrial tRNA species purified from A.suum, 10 of which lacked a T-arm and one of which lacked a D-arm. The most characteristic feature of nematode mitochondrial tRNAs lacking a T-arm was the presence of 1-methyladenosine at position 9 (m1A9). Synthesis of T-armless tRNAs with or without the modified nucleoside showed that T-armless tRNAs without the modification had much lower aminoacylation and EF-Tu-binding activities than native tRNAs. The addition of a single methyl group to A9 of these tRNAs was sufficient to restore nearly native levels of aminoacylation and EF-Tu-binding activity as well as tertiary structure, suggesting that m1A9 is a key residue for the activity of T-armless tRNAs. Thus, m1A9 is indispensable for the structure and function of T-armless tRNAs of nematode mitochondrial origin.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15781491 PMCID: PMC1069008 DOI: 10.1093/nar/gki309
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1Diagrams showing how A.suum mt tRNAs(m1A9+) were constructed. The sequences of RNA fragments [F1/M1, F2/M2 and F3/M3] are described in Materials and Methods. The m1A9 is described as the filled circle. The chemically synthesized tRNAs containing m1A9 were further converted to molecules bearing 5′-phosphates and 3′-OH ends.
Modified nucleotides detected in the individual tRNAs from the nematode, A.suum
| TRNA | Lacking arm | 9 | 26 | 34 | 37 | Other |
|---|---|---|---|---|---|---|
| Leu(UAA) | T | m1A | U | m1G | Ψ (2, 27, 28, 31, 32, 40) | |
| Trp | T | m1A | U | ms2i6A | Ψ (27, 28, 31, 32, 70) | |
| Gln | T | m1A | U | m1G | Ψ (27, 31, 32, 38, 40, 71) | |
| Lys | T | m1A | m22G | U | t6A | Ψ (25, 27, 28, 39, 69) |
| Glu | T | m1A | U | m1G | Ψ (25, 27, 29, 32, 71) | |
| Tyr | T | m1A | Q | ms2i6A | Ψ | |
| His | T | m1A | Q | Ψ | ||
| Asp | T | m1A | Q | m1G | Ψ | |
| Asn | T | m1A | Q | m1G | Ψ | |
| Cys | T | m1A | m1G | Ψ | ||
| Arg | T | m1A | m1G | m1A8, Ψ (25, 29, 32, 38, 40, 71) | ||
| Met | T | m1A | m2G | f5C | Ψ (3, 27, 71) | |
| Phe | T | m1A | m1G | Ψ (25, 27, 31, 32) | ||
| Ser(UGA) | D | ms2i6A | Ψ | |||
| Ser(UCU) | D | t6A | Ψ (26, 40, 67) |
The numbers in the parentheses indicate the positions of modified nucleosides. Each residue is numbered according to (1,2). Abbreviations; m22G, N2,N2-dimethylguanosine; m2G, N2-methylguanosine; Q, queuosine; f5C, 5-formylcytidine; m1G, 1-methylguanosine; ms2i6A, N6-(3-methyl-2-butenyl)-2-methylthioadenosine; t6A, N6-threonylcarbamoyladenosine; Ψ, pseudouridine.
*aModified uridines. Details will be described in other manuscript (Sakurai et al., in preparation)
*bPositions of modified nucleotides in tRNAs for Tyr, His, Asp, Asn, Cys and Ser(UGA) were investigated by LC/MS analysis of RNase T1-digested tRNA (data not shown). The location of each Ψ could not be determined by this analysis because its molecular mass is same as uridine.
*c*dThese results were already described in Watanabe et al. (20) and (10), respectively.
Figure 2(A) Two-dimensional thin layer chromatography of modified nucleosides at position 9 of mitochondrial tRNAs. Open circles indicate spots of nucleotides (A, U, G and C bearing 5′-phosphate) detected by UV shadowing. Open and filled triangles indicate m1A and m6A [which is considered to be converted form of m1A (21)], respectively. Nucleotide analysis was performed as follows. Each 3′ fragment generated by alkaline digestion of the tRNA was labeled at its 5′ terminus with [γ-32P]ATP and T4 polynucleotide kinase. Labeled RNAs were loaded onto 10% denaturing polyacrylamide gel and each 5′-labeled 3′-fragment was excised from the gel. The fragments were then digested with P1 nuclease and the resulting 5′-labeled mononucleotides were analyzed by TLC. 2D-TLC analyses were performed using the solvents; isobutyric acid/concentrated ammonia/water (66:1:33, v/v/v) for the first dimension in both systems, 2-propanol/HCl/water (70:15:15, v/v/v) for the second dimension in system A, and ammonium sulfate/0.1 M sodium phosphate, pH 6.8/1-propanol (60 g:100 ml:2 ml) for the second dimension in system B. 5′-nucleotides of tRNAs were also detected by TLC because each 5′-fragment generated by alkaline digestion of the tRNA was also labeled at its 5′-terminus by the phosphorylation reaction described above (although the 5′-fragment had 5′-phosphate even before the reaction, the 5′-phosphate may have exchanged with labeled phosphate of [γ-32P]ATP), and the 5′-labeled 5′-fragments migrated together with the 5′-labeled 3′-fragments on the gel. (B) Nucleotide sequences of A.suum mt tRNAs. Abbreviations are the same as in Table 1. Asterisks (*) show modified uridines, whose details will be described in another manuscript (Sakurai et al., in preparation).
Figure 3Aminoacylation activities of A.suum mt tRNAPhe (left) and tRNAMet (right) with three different forms. Open squares, unmodified tRNAs; open circles, native tRNAs; filled circles, tRNAs(m1A9+). Blank value at each time point, which was measured by same procedures using the reaction mixture without tRNA, was subtracted from each raw data.
Figure 4Deacylation-protection assay of the aminoacyl ester bond against hydrolysis (19) of A.suum mt Phe-tRNAPhe (initial concentration: 50 nM) (left) and A.suum mt Met-tRNAMet (initial concentration: 50 nM) (right) in the presence of 5 μM C.elegans mt EF-Tu1/Ts complex. Unmodified tRNAs (squares), tRNAs(m1A9+) (triangles) and native tRNAs (circles) were analyzed. Filled and open symbols show the deacylation profile with and without EF-Tu1/Ts, respectively.
Figure 5Enzymatic probing of modification variants of 5′- or 3′-labeled A.suum mt tRNAPhe and tRNAMet. (A) Labeled tRNAsPhe were reacted with 0.009 or 0.003 U/μl of RNase V1 and 0.000012 or 0.000004 U/μl of RNase T2. Open triangles indicate the amounts of RNases. Symbols: −, untreated tRNA; N, alkaline ladder; G, RNase T1 ladder; Nc, ladder of digestion with Neurospora crassa endonuclease as a size marker of RNaseV1, which digest at the 5′ side of phosphodiester bonds. (B and C) Summary of enzymatic probing of modification variants of the tRNAPhe and tRNAMet. Filled and open triangles indicate the cleavage sites with RNaseT2 and RNaseV1, respectively (the cleavage strengths are shown by the triangle sizes).